| Product Code: ETC7636606 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Ireland continued to see a significant amount of pegylated proteins import shipments, with the top countries exporting being the USA, UK, Germany, Metropolitan France, and Serbia. Despite a high concentration in market share, the industry experienced a negative compound annual growth rate (CAGR) of -4.18% from 2020 to 2024. Additionally, the growth rate from 2023 to 2024 was notably steep at -30.16%, indicating potential challenges or shifts in the market dynamics during that period. It will be interesting to monitor how these trends evolve and impact the import landscape in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland PEGylated Proteins Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland PEGylated Proteins Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland PEGylated Proteins Market - Industry Life Cycle |
3.4 Ireland PEGylated Proteins Market - Porter's Five Forces |
3.5 Ireland PEGylated Proteins Market Revenues & Volume Share, By Product & Services, 2021 & 2031F |
3.6 Ireland PEGylated Proteins Market Revenues & Volume Share, By Protein Type, 2021 & 2031F |
3.7 Ireland PEGylated Proteins Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Ireland PEGylated Proteins Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Ireland PEGylated Proteins Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring long-term treatment with pegylated proteins. |
4.2.2 Growing adoption of pegylated proteins in biopharmaceutical research and development. |
4.2.3 Technological advancements leading to the development of more efficient and targeted pegylated protein therapies. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of pegylated protein drugs. |
4.3.2 High cost associated with the production and development of pegylated proteins. |
4.3.3 Limited awareness among healthcare professionals and patients about the benefits of pegylated protein therapies. |
5 Ireland PEGylated Proteins Market Trends |
6 Ireland PEGylated Proteins Market, By Types |
6.1 Ireland PEGylated Proteins Market, By Product & Services |
6.1.1 Overview and Analysis |
6.1.2 Ireland PEGylated Proteins Market Revenues & Volume, By Product & Services, 2021- 2031F |
6.1.3 Ireland PEGylated Proteins Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.4 Ireland PEGylated Proteins Market Revenues & Volume, By Services, 2021- 2031F |
6.2 Ireland PEGylated Proteins Market, By Protein Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland PEGylated Proteins Market Revenues & Volume, By Colony-stimulating Factor, 2021- 2031F |
6.2.3 Ireland PEGylated Proteins Market Revenues & Volume, By Interferons, 2021- 2031F |
6.2.4 Ireland PEGylated Proteins Market Revenues & Volume, By Erythropoietin, 2021- 2031F |
6.2.5 Ireland PEGylated Proteins Market Revenues & Volume, By Recombinant Factor VII, 2021- 2031F |
6.2.6 Ireland PEGylated Proteins Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland PEGylated Proteins Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Ireland PEGylated Proteins Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.3 Ireland PEGylated Proteins Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.3.4 Ireland PEGylated Proteins Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.3.5 Ireland PEGylated Proteins Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.3.6 Ireland PEGylated Proteins Market Revenues & Volume, By Hemophilia, 2021- 2031F |
6.3.7 Ireland PEGylated Proteins Market Revenues & Volume, By Gastrointestinal Disorders, 2021- 2031F |
6.4 Ireland PEGylated Proteins Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 Ireland PEGylated Proteins Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.3 Ireland PEGylated Proteins Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F |
6.4.4 Ireland PEGylated Proteins Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
7 Ireland PEGylated Proteins Market Import-Export Trade Statistics |
7.1 Ireland PEGylated Proteins Market Export to Major Countries |
7.2 Ireland PEGylated Proteins Market Imports from Major Countries |
8 Ireland PEGylated Proteins Market Key Performance Indicators |
8.1 Patient adherence rate to pegylated protein therapies. |
8.2 Number of clinical trials and research studies utilizing pegylated proteins. |
8.3 Rate of adoption of pegylated protein therapies in different disease indications. |
9 Ireland PEGylated Proteins Market - Opportunity Assessment |
9.1 Ireland PEGylated Proteins Market Opportunity Assessment, By Product & Services, 2021 & 2031F |
9.2 Ireland PEGylated Proteins Market Opportunity Assessment, By Protein Type, 2021 & 2031F |
9.3 Ireland PEGylated Proteins Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Ireland PEGylated Proteins Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Ireland PEGylated Proteins Market - Competitive Landscape |
10.1 Ireland PEGylated Proteins Market Revenue Share, By Companies, 2024 |
10.2 Ireland PEGylated Proteins Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |